EYPT EyePoint, Inc. - Common Stock
$5,96
Preço · Ago 19, 2026
Fundamentais a partir de Ago 5, 2026
Intervalo 52 Semanas
$4–$19
13% of range
Classificação do Analista
BUY
20 analysts
Preço-Alvo
$37
+514% upside
P/E (TTM)
-1.9
ROE
-84.0%
Margem de Lucro Líquido
-739.4%
Sobre EyePoint, Inc. - Common Stock Visão geral da empresa da Wikipedia
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Ler mais
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
EYPT Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$5.96
Capitalização de Mercado
$494M
P/E (TTM)
-1.9
EPS (TTM)
$-3.17
Receita (TTM)
$31M
Rendimento div.
—
ROE
-84.0%
Dívida/Capital
—
Intervalo 52 Semanas
$4 – $19
EYPT Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$31M
2017-06-30
→
2025-12-31
EPS
$-3.17
2017-06-30
→
2025-12-31
Fluxo de caixa livre
$-243M
2019-12-31
→
2025-12-31
Margens
-739.4%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
EYPT
Mediana de Pares
P/E (TTM)
-1.9
29.9
P/S (TTM)
15.7
14.4
P/B
1.6
4.4
Price / FCF (Preço / FCF)
-2.0
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
EYPT
Mediana de Pares
Operating Margin (Margem Operacional)
-776.0%
—
Net Profit Margin (Margem de Lucro Líquido)
-739.4%
0.70%
ROA
-59.3%
-0.55%
ROE
-84.0%
-2.5%
ROIC
-79.6%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
EYPT
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
8.9
3.9
Quick Ratio (Índice de Liquidez Seca)
8.3
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
EYPT
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-27.5%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-8.8%
—
Revenue CAGR 5Y (CAGR Receita 5A)
-1.8%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
EYPT
Mediana de Pares
EYPT Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
20 analistas
- Compra forte 7 35,0%
- Compra 12 60,0%
- Manter 1 5,0%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
13 analistas · 2026-08-19
Mediana
$37.00
← Abaixo de todos os alvos
$5.96
Mín
$8.00
Máx
$68.00
Alvo mediano
$37.00
+520,8%
Alvo médio
$36.62
+514,4%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-0.07%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-1.09 | $-0.97 | -0.12% |
| 31 de Março de 2026 | $-0.99 | $-0.82 | -0.17% |
| 31 de Dezembro de 2025 | $-0.81 | $-0.76 | -0.05% |
| 30 de Setembro de 2025 | $-0.85 | $-0.80 | -0.05% |
| 30 de Junho de 2025 | $-0.85 | $-0.81 | -0.04% |
| 31 de Março de 2025 | $-0.65 | $-0.67 | 0.02% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| XERS | $1.30B | — | 43.7% | 0.19% | -19.7% | — |
| PAHC | — | 21.5 | 27.4% | 3.7% | 17.8% | 30.9% |
| SPTX | — | — | — | — | — | — |
| ANRO | $568M | -8.1 | — | — | -46.1% | — |
| OMER | $1.23B | -343.6 | — | — | 1.9% | — |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | — |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $43M | $46M | $41M | $37M | $34M | $20M | $5M | $8M | $2M | $27M | |
| R&D Expense | $221M | $133M | $65M | $50M | $28M | $17M | $15M | $19M | $15M | $14M | $12M | |
| SG&A Expense | $52M | $52M | $40M | $35M | $26M | $21M | $18M | $15M | $11M | $9M | $8M | |
| Operating Expenses | $275M | $189M | $121M | $141M | $92M | $72M | $68M | $44M | $26M | $23M | $20M | |
| Operating Income | $-243M | $-146M | $-75M | $-100M | $-55M | $-37M | $-48M | $-39M | $-19M | $-22M | $6M | |
| Interest Expense | · | · | $1M | $3M | $5M | $7M | $6M | $2M | $0 | $0 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $12M | $15M | $7M | $2M | $292.0K | $58.0K | $1M | $420.0K | $91.0K | $72.0K | $22.0K | |
| Pretax Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Income Tax | $279.0K | $90.0K | $83.0K | · | $0 | $0 | $0 | · | $0 | $-155.0K | $96.0K | |
| Net Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | $-86M | $-18M | $-22M | $6M | |
| EPS (Basic) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.22 | |
| EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.21 | |
| Shares (Basic) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 29,378,250 | |
| Shares (Diluted) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 30,584,140 | |
| EBITDA | $-241M | $-146M | $-75M | $-100M | $-55M | · | $-48M | · | · | $-22M | $6M |
Balanço Patrimonial 27
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $100M | $281M | $96M | $179M | $45M | $22M | $45M | $17M | $15M | $19M | |
| Short-term Investments | $204M | $271M | $50M | $49M | $33M | $0 | $0 | $0 | $0 | $14M | $9M | |
| Inventory | $2M | $2M | $4M | $3M | $4M | $5M | $2M | $279.0K | · | · | · | |
| Prepaid Expense | $20M | $9M | $9M | $10M | $4M | $3M | $6M | $1M | $591.0K | $483.0K | $681.0K | |
| Other Current Assets | $2M | $1M | $1M | $782.0K | $517.0K | · | · | · | · | · | · | |
| Current Assets | $329M | $383M | $345M | $173M | $238M | $63M | $42M | $48M | $18M | $30M | $30M | |
| PP&E (Net) | $9M | $8M | $5M | $1M | $476.0K | $630.0K | $357.0K | $288.0K | $313.0K | $290.0K | $338.0K | |
| PP&E (Gross) | $15M | $12M | $8M | $3M | $2M | $2M | $1M | $983.0K | $799.0K | $2M | $2M | |
| Accum. Depreciation | $6M | $4M | $3M | $2M | $1M | $1M | $839.0K | $695.0K | $486.0K | $2M | $2M | |
| Intangibles | · | · | · | $0 | $23M | $25M | $28M | $30M | $364.0K | $1M | $2M | |
| Other Non-current Assets | $6M | $6M | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Accounts Payable | $10M | $12M | $7M | $6M | $7M | $5M | $4M | $3M | $1M | $1M | $744.0K | |
| Accrued Liabilities | $24M | $18M | $18M | $16M | $14M | $8M | $7M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | $0 | $10M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $37M | $49M | $63M | $35M | $24M | $15M | $12M | $21M | $5M | $5M | $3M | |
| Capital Leases | $21M | $22M | $5M | $6M | $2M | $2M | $3M | $0 | · | · | · | |
| Other Non-current Liabilities | $87.0K | $205.0K | $0 | $600.0K | $2M | $2M | $3M | $1M | $51.0K | · | · | |
| Total Liabilities | $58M | $82M | $89M | $84M | $79M | $73M | $65M | $41M | $5M | $11M | $9M | |
| Long-term Debt | · | · | · | $30M | · | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $40M | $37M | · | $47M | · | · | · | · | |
| Common Stock | $83.0K | $68.0K | $49.0K | $34.0K | $34.0K | $18.0K | $11.0K | $95.0K | $39.0K | $34.0K | $29.0K | |
| Retained Earnings | $-1.10B | $-873M | $-742M | $-671M | $-569M | $-511M | $-465M | $-408M | $-311M | $-292M | $-271M | |
| AOCI | $961.0K | $1M | $864.0K | $786.0K | $841.0K | $841.0K | $840.0K | $839.0K | $833.0K | $852.0K | $945.0K | |
| Stockholders' Equity | $306M | $337M | $266M | $96M | $184M | $19M | $8M | $38M | $13M | $21M | $23M | |
| Liabilities + Equity | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Shares Outstanding | 82,826,416 | 68,266,005 | 49,043,074 | 34,082,934 | 33,905,826 | 18,139,981 | 10,941,659 | 95,372,236 | 39,356,999 | 34,172,919 | 29,412,365 |
Fluxo de Caixa 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $464.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $28M | $37M | $12M | $14M | $7M | $6M | $5M | · | $2M | $2M | $2M | |
| Deferred Tax | $279.0K | $90.0K | $83.0K | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $0 | $2M | $2M | $2M | $2M | $981.0K | $724.0K | $756.0K | $770.0K | |
| Restructuring | · | · | · | · | · | $590.0K | · | · | $472.0K | · | · | |
| Other Non-cash | $-39M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-240M | $-126M | $2M | $-65M | $-50M | $-14M | $-57M | · | $-20M | $-16M | $10M | |
| CapEx | $3M | $4M | $3M | $2M | $156.0K | $362.0K | $213.0K | · | $147.0K | $113.0K | $161.0K | |
| Investing Cash Flow | $69M | $-219M | $-3M | $-17M | $-33M | $-362.0K | $-213.0K | · | $14M | $-4M | · | |
| Debt Issued | · | · | $0 | $30M | $0 | · | $50M | · | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $-30M | $-8M | $0 | · | $30M | · | · | · | · | |
| Stock Issued | $173M | $163M | $226M | $0 | · | $50M | $23M | · | $8M | $16M | $0 | |
| Net Stock Activity | $173M | $163M | $226M | · | · | · | $23M | · | · | $16M | · | |
| Financing Cash Flow | $174M | $164M | $187M | $-690.0K | $217M | $37M | $34M | · | $9M | $17M | · | |
| Net Change in Cash | $2M | $-182M | $186M | $-83M | $134M | $23M | $-23M | · | $2M | $-4M | $4M | |
| Taxes Paid | $200.0K | $100.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-243M | $-130M | $-2M | $-67M | $-50M | · | $-57M | · | · | $-16M | $10M | |
| Levered FCF | · | · | $-3M | $-70M | $-56M | · | $-63M | · | · | · | · |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | · | -278.9% | · | · | -1330.1% | 23.9% | |
| Pretax Margin | -738.5% | -302.2% | -153.7% | -247.0% | -158.1% | · | -278.9% | · | · | -1339.6% | 24.2% | |
| EBITDA Margin | -768.6% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| ROA | -59.3% | -33.8% | -26.4% | -46.1% | -32.9% | · | -75.1% | · | · | -67.3% | 23.1% | |
| ROE | -84.0% | -47.1% | -43.6% | -87.9% | -42.2% | · | -468.1% | · | · | -90.8% | 24.8% | |
| ROIC | -79.6% | -43.4% | -28.2% | -73.2% | -25.0% | · | -86.2% | · | · | -103.5% | 27.1% |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 | · | 3.6 | · | · | 5.9 | 8.9 | |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 | · | 1.9 | · | · | 5.7 | 8.5 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.2 | · | 5.7 | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.3 | 0.2 | · | 5.7 | · | · | · | · | |
| Interest Coverage | · | · | -60.2 | -31.2 | -10.1 | · | -7.7 | · | · | · | · |
Eficiência 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | · | 0.1 | 1.0 |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -27.5% | -6.0% | 11.1% | 12.1% | 7.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | 5.4% | 10.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $43M | $46M | $41M | $37M | $34M | $20M | · | $8M | $2M | $27M | |
| Net Income TTM | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Market Cap | $1.51B | $509M | $1.13B | $119M | $415M | · | $1.70B | · | · | $967M | $1.11B | |
| Enterprise Value | · | · | $802M | $15M | $240M | · | $1.72B | · | · | · | · | |
| P/E | -5.8 | -3.2 | -12.7 | -1.3 | -6.0 | -9.8 | -23.1 | · | -32.9 | -41.6 | 179.5 | |
| P/S | 48.2 | 11.8 | 24.6 | 2.9 | 11.2 | · | 83.3 | · | · | 597.0 | 41.7 | |
| P/B | 4.9 | 1.5 | 4.3 | 1.2 | 2.3 | · | 203.6 | · | · | 46.3 | 47.5 | |
| P / Tangible Book | 4.9 | 1.5 | 4.3 | 1.2 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | -6.3 | -4.0 | 604.5 | -1.8 | -8.3 | · | -29.9 | · | · | -59.3 | 107.7 | |
| P / FCF | -6.2 | -3.9 | -704.8 | -1.8 | -8.3 | · | -29.8 | · | · | -58.9 | 109.4 | |
| EV / EBITDA | · | · | -10.7 | -0.1 | -4.3 | · | -36.0 | · | · | · | · | |
| EV / FCF | · | · | -499.0 | -0.2 | -4.8 | · | -30.2 | · | · | · | · | |
| EV / Revenue | · | · | 17.4 | 0.4 | 6.5 | · | 84.5 | · | · | · | · | |
| Earnings Yield | -17.3% | -31.1% | -7.9% | -78.3% | -16.6% | -10.2% | -4.3% | · | -3.0% | -2.4% | 0.56% |
Demonstração de Resultados 16
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.0K | $696.0K | $619.0K | $966.0K | $5M | $24M | $12M | $11M | $9M | $12M | $14M | $15M | $9M | $8M | $11M | $10M | |
| Cost of Revenue | · | · | · | · | · | · | · | $736.0K | $1M | $759.0K | · | $1M | $2M | $640.0K | · | · | |
| R&D Expense | $84M | $72M | $59M | $48M | $55M | $59M | $43M | $30M | $30M | $30M | $18M | $17M | $16M | $14M | $16M | $11M | |
| SG&A Expense | $14M | $15M | $11M | $14M | $12M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | $9M | $9M | $8M | $9M | |
| Operating Expenses | $98M | $88M | $71M | $63M | $68M | $73M | $57M | $43M | $44M | $45M | $30M | $30M | $32M | $29M | $54M | $28M | |
| Operating Income | $-97M | $-87M | $-70M | $-62M | $-62M | $-49M | $-45M | $-33M | $-35M | $-33M | $-16M | $-14M | $-23M | $-22M | $-44M | $-18M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $435.0K | $812.0K | $781.0K | $662.0K | |
| Other Non-op | $3M | $2M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $640.0K | |
| Pretax Income | $-94M | · | $-67M | $-60M | $-59M | · | $-41M | $-29M | $-31M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $-50.0K | $186.0K | $0 | $93.0K | $0 | $90.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-94M | $-85M | $-68M | $-60M | $-59M | $-45M | $-41M | $-29M | $-31M | $-29M | $-14M | $-13M | $-23M | $-21M | $-43M | $-18M | |
| EPS (Basic) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| EPS (Diluted) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| Shares (Basic) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| Shares (Diluted) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| EBITDA | $-97M | $-87M | · | $-62M | $-62M | $-49M | · | $-33M | $-35M | $-33M | · | $-14M | $-23M | $-22M | · | $-18M |
Balanço Patrimonial 27
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $78M | $102M | $75M | $71M | $85M | $100M | $80M | $91M | $271M | $281M | $133M | $140M | $106M | $96M | $75M | |
| Short-term Investments | $70M | $145M | $204M | $129M | $185M | $233M | $271M | $174M | $189M | $28M | $50M | $3M | $3M | $17M | $49M | $82M | |
| Inventory | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | |
| Prepaid Expense | $6M | $25M | $20M | $9M | $6M | $6M | $9M | $12M | $10M | $11M | $9M | $9M | $9M | $9M | $10M | $10M | |
| Other Current Assets | $987.0K | $1M | $2M | $899.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $549.0K | $0 | $0 | $782.0K | · | |
| Current Assets | $189M | $250M | $329M | $216M | $265M | $327M | $383M | $269M | $295M | $318M | $345M | $150M | $167M | $146M | $173M | $192M | |
| PP&E (Net) | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $1M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $12M | · | · | · | $8M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Other Non-current Assets | $9M | $9M | $6M | $6M | $6M | $6M | $6M | $2M | · | · | $0 | · | · | · | · | · | |
| Total Assets | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Accounts Payable | $17M | $19M | $10M | $10M | $20M | $16M | $12M | $7M | $14M | $7M | $7M | $10M | $11M | $9M | $6M | $6M | |
| Accrued Liabilities | $22M | $16M | $24M | $18M | $11M | $18M | $18M | $14M | $13M | $16M | $18M | $13M | $15M | $10M | $16M | $16M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $5M | $10M | $10M | |
| Current Liabilities | $42M | $37M | $37M | $30M | $33M | $42M | $49M | $49M | $62M | $63M | $63M | $64M | $69M | $27M | $35M | $34M | |
| Capital Leases | $20M | $20M | $21M | $21M | $22M | $22M | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Other Non-current Liabilities | $23.0K | $55.0K | $87.0K | $118.0K | $148.0K | $177.0K | $205.0K | $233.0K | · | · | $0 | $0 | $0 | $600.0K | $600.0K | $600.0K | |
| Total Liabilities | $62M | $58M | $58M | $52M | $55M | $64M | $82M | $82M | $96M | $79M | $89M | $101M | $118M | $76M | $84M | $84M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $35M | · | $40M | |
| Common Stock | $85.0K | $83.0K | $83.0K | $70.0K | $69.0K | $69.0K | $68.0K | $53.0K | $52.0K | $50.0K | $49.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | |
| Retained Earnings | $-1.28B | $-1.19B | $-1.10B | $-1.04B | $-978M | $-918M | $-873M | $-832M | $-802M | $-771M | $-742M | $-728M | $-715M | $-693M | $-671M | $-628M | |
| AOCI | $793.0K | $802.0K | $961.0K | $919.0K | $832.0K | $923.0K | $1M | $1M | $792.0K | $836.0K | $864.0K | $841.0K | $842.0K | $843.0K | $786.0K | $653.0K | |
| Stockholders' Equity | $166M | $230M | $306M | $200M | $246M | $298M | $337M | $219M | $228M | $250M | $266M | $59M | $57M | $78M | $96M | $136M | |
| Liabilities + Equity | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Shares Outstanding | 84,981,843 | 83,453,001 | 82,826,416 | 69,569,813 | 68,889,649 | 68,811,357 | 68,266,005 | 53,524,364 | 52,160,305 | 49,885,701 | 49,043,074 | 35,309,432 | 34,306,118 | 34,301,926 | 34,082,934 | 34,072,155 |
Fluxo de Caixa 14
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $690.0K | $636.0K | $698.0K | $576.0K | $538.0K | $497.0K | $467.0K | $408.0K | $362.0K | $303.0K | $112.0K | · | · | · | · | · | |
| Stock-based Comp | $10M | $12M | $7M | $6M | $7M | $8M | $8M | $7M | $9M | $13M | $4M | $4M | $2M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $369.0K | $0 | · | · | $90.0K | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $205.0K | $615.0K | |
| Other Non-cash | · | $-8M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-81M | $-65M | $-59M | $-63M | $-53M | $-36M | $-39M | $-20M | $-31M | $-23M | $-15M | $57M | $-17M | $-13M | $-13M | |
| CapEx | $1M | $997.0K | $986.0K | $798.0K | $1M | $276.0K | $384.0K | $2M | $900.0K | $1M | $883.0K | $2M | $396.0K | $484.0K | $585.0K | $1M | |
| Investing Cash Flow | $75M | $59M | $-75M | $55M | $48M | $40M | $-96M | $16M | $-160M | $21M | $-47M | $-2M | $13M | $32M | $33M | $6M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $167M | $7M | · | · | $152M | · | · | · | $216M | · | · | · | $0 | · | |
| Financing Cash Flow | $20M | $-3M | $167M | $7M | $238.0K | $-951.0K | $152M | $12M | $329.0K | $115.0K | $218M | $10M | $-37M | $-5M | $-58.0K | $92.0K | |
| Net Change in Cash | $33M | $-24M | $27M | $3M | $-14M | $-15M | $20M | $-11M | $-180M | $-10M | $148M | $-7M | $34M | $10M | $20M | $-7M | |
| Free Cash Flow | · | $-82M | · | · | · | $-53M | · | · | · | $-32M | · | · | · | $-17M | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19207.1% | -12532.5% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| Net Margin | -18633.1% | -12188.5% | · | -6183.4% | -1114.3% | -184.8% | · | -279.0% | -325.3% | -250.6% | · | -83.0% | -251.7% | -275.5% | · | -184.0% | |
| Pretax Margin | -18633.1% | · | · | -6183.4% | -1112.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -19207.1% | -12441.1% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| ROA | -35.7% | -26.1% | · | -21.6% | -19.0% | -13.1% | · | -12.7% | -12.3% | -12.1% | · | -6.6% | -11.2% | -10.6% | · | -9.5% | |
| ROE | -45.8% | -32.1% | · | -28.5% | -25.1% | -16.5% | · | -21.2% | -21.6% | -17.8% | · | -12.9% | -22.0% | -17.3% | · | -16.1% | |
| ROIC | -58.5% | · | · | -31.0% | -25.3% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez e Solvência 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.7 | · | 7.2 | 8.0 | 7.8 | · | 5.5 | 4.7 | 5.1 | · | 2.4 | 2.4 | 5.4 | · | 5.6 | |
| Quick Ratio | 4.3 | 5.9 | · | 6.8 | 7.7 | 7.6 | · | 5.2 | 4.5 | 4.8 | · | 2.1 | 2.1 | 4.5 | · | 4.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -52.3 | -26.5 | · | -27.8 |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.2 | 0.4 | 0.2 | · | · | · | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $31M | · | $41M | $50M | $56M | · | $47M | $45M | $44M | · | $42M | $38M | $39M | · | $40M | |
| Net Income TTM | $-298M | $-249M | · | $-194M | $-165M | $-135M | · | $-102M | $-96M | $-86M | · | $-75M | $-82M | $-80M | · | $-75M | |
| Market Cap | $1.22B | $1.08B | · | $991M | $648M | $373M | · | $428M | $454M | $1.03B | · | $282M | $298M | $101M | · | $270M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $146M | $156M | $13M | · | $152M | |
| P/E | -3.8 | -3.9 | · | -4.9 | -3.6 | -2.3 | · | -4.0 | -4.2 | -10.1 | · | -4.0 | -4.0 | -1.4 | · | -3.7 | |
| P/S | 162.0 | 34.2 | · | 24.0 | 13.0 | 6.6 | · | 9.1 | 10.0 | 23.6 | · | 6.7 | 7.8 | 2.6 | · | 6.7 | |
| P/B | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.0 | |
| P / Tangible Book | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -7.0 | · | · | · | -33.1 | · | · | · | -6.0 | · | · | |
| P / FCF | · | -13.2 | · | · | · | -7.0 | · | · | · | -31.9 | · | · | · | -5.8 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -10.1 | -6.9 | -0.6 | · | -8.3 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -0.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 3.5 | 4.1 | 0.3 | · | 3.8 | |
| Earnings Yield | -26.4% | -25.9% | · | -20.3% | -27.8% | -42.8% | · | -25.0% | -23.8% | -9.9% | · | -24.9% | -25.1% | -72.5% | · | -27.2% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $31M | $43M | $46M | $41M | $37M |
| Margem Operacional % | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% |
| Lucro líquido | $-232M | $-131M | $-71M | $-102M | $-58M |
| EPS Diluído | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | — | — | 0.0 | 0.4 | 0.2 |
| Índice de liquidez corrente | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 |
| Índice de Liquidez Seca | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-243M | $-130M | $-2M | $-67M | $-50M |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 217 declarantes · $1.2B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 37 (-18 vs trimestre anterior) | 20 (-3 vs trimestre anterior) | 63 (-9 vs trimestre anterior) | 56 (+18 vs trimestre anterior) | +8.5M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $118.638.163 | 8.296.375 | 10,19% | Ações |
| Cormorant Asset Management, LP | $100.100.000 | 7.000.000 | 8,60% | Ações |
| VANGUARD GROUP INC | $78.353.343 | 4.288.634 | 6,73% | Ações |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $69.037.426 | 4.827.792 | 5,93% | Ações |
| Commodore Capital LP | $65.780.000 | 4.600.000 | 5,65% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $51.912.604 | 3.630.252 | 4,46% | Ações |
| JANUS HENDERSON GROUP PLC | $45.962.750 | 3.565.768 | 3,95% | Ações |
| Paradigm Biocapital Advisors LP | $41.332.677 | 2.890.397 | 3,55% | Ações |
| STATE STREET CORP | $33.712.894 | 2.357.545 | 2,90% | Ações |
| Aberdeen Group plc | $28.725.869 | 2.008.802 | 2,47% | Ações |
| PERCEPTIVE ADVISORS LLC | $28.600.000 | 2.000.000 | 2,46% | Opção de venda |
| Balyasny Asset Management L.P. | $25.916.719 | 1.812.358 | 2,23% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $25.269.659 | 1.766.745 | 2,17% | Ações |
| CITADEL ADVISORS LLC | $25.214.389 | 1.763.244 | 2,17% | Ações |
| Parkman Healthcare Partners LLC | $18.420.731 | 1.288.163 | 1,58% | Ações |
| EVENTIDE ASSET MANAGEMENT, LLC | $17.811.837 | 1.245.583 | 1,53% | Ações |
| TWO SIGMA INVESTMENTS, LP | $16.890.345 | 1.181.143 | 1,45% | Ações |
| Essex Woodlands Management, Inc. | $15.513.455 | 1.084.857 | 1,33% | Ações |
| ORBIMED ADVISORS LLC | $15.288.802 | 1.069.147 | 1,31% | Ações |
| 5AM Venture Management, LLC | $15.015.000 | 1.050.000 | 1,29% | Ações |
| Rosalind Advisors, Inc. | $14.131.689 | 988.230 | 1,21% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.885.500 | 971.014 | 1,19% | Ações |
| HSBC HOLDINGS PLC | $11.918.407 | 833.455 | 1,02% | Ações |
| Candriam S.C.A. | $11.254.258 | 787.769 | 0,97% | Ações |
| AMERIPRISE FINANCIAL INC | $11.087.640 | 775.357 | 0,95% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $11.062.981 | 773.635 | 0,95% | Ações |
| Artia Global Partners LP | $10.969.501 | 767.098 | 0,94% | Ações |
| Blue Owl Capital Holdings LP | $10.905.094 | 762.594 | 0,94% | Ações |
| Patient Square Capital LP | $10.296.000 | 720.000 | 0,88% | Ações |
| Principia Wealth Advisory, LLC | $9.696.346 | 530.725 | 0,83% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.260.866 | 647.613 | 0,80% | Ações |
| Sio Capital Management, LLC | $8.910.759 | 623.130 | 0,77% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $7.996.789 | 559.216 | 0,69% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.899.320 | 552.400 | 0,68% | Opção de compra |
| Alyeska Investment Group, L.P. | $7.284.463 | 509.403 | 0,63% | Ações |
| MILLENNIUM MANAGEMENT LLC | $7.151.330 | 500.093 | 0,61% | Ações |
| Simplify Asset Management Inc. | $5.720.629 | 400.044 | 0,49% | Ações |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,46% | Opção de compra |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,46% | Opção de venda |
| Ghisallo Capital Management LLC | $5.005.000 | 350.000 | 0,43% | Ações |
| STEMPOINT CAPITAL LP | $4.840.135 | 338.471 | 0,42% | Ações |
| E Fund Management Co., Ltd. | $4.730.068 | 330.774 | 0,41% | Ações |
| Jump Financial, LLC | $4.586.825 | 320.757 | 0,39% | Ações |
| Bleichroeder LP | $4.526.165 | 316.515 | 0,39% | Ações |
| Woodline Partners LP | $4.296.621 | 300.463 | 0,37% | Ações |
| Eversept Partners, LP | $4.257.610 | 297.735 | 0,37% | Ações |
| GOLDMAN SACHS GROUP INC | $4.086.797 | 285.790 | 0,35% | Ações |
| Rock Springs Capital Management LP | $3.839.822 | 268.519 | 0,33% | Ações |
| CITIGROUP INC | $3.750.032 | 262.240 | 0,32% | Ações |
| MYDA Advisors LLC | $3.575.000 | 250.000 | 0,31% | Ações |
| AXA Investment Managers S.A. | $3.480.640 | 244.427 | 0,30% | Ações |
| UBS Group AG | $3.373.442 | 235.905 | 0,29% | Ações |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.342.639 | 233.751 | 0,29% | Ações |
| Schonfeld Strategic Advisors LLC | $3.285.853 | 229.780 | 0,28% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.038.750 | 212.500 | 0,26% | Opção de venda |
| Propel Bio Management, LLC | $2.741.954 | 191.745 | 0,24% | Ações |
| Qube Research & Technologies Ltd | $2.704.159 | 189.102 | 0,23% | Ações |
| Walleye Capital LLC | $2.691.560 | 188.221 | 0,23% | Ações |
| Susquehanna Portfolio Strategies, LLC | $2.685.554 | 187.801 | 0,23% | Ações |
| BlackRock, Inc. | $2.649.890 | 185.307 | 0,23% | Ações |
| CITADEL ADVISORS LLC | $2.559.700 | 179.000 | 0,22% | Opção de venda |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2.389.303 | 169.334 | 0,21% | Ações |
| HighVista Strategies LLC | $2.226.567 | 155.704 | 0,19% | Ações |
| Granahan Investment Management, LLC | $2.136.234 | 149.387 | 0,18% | Ações |
| Swiss National Bank | $2.034.890 | 142.300 | 0,17% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.998.711 | 139.770 | 0,17% | Ações |
| PANAGORA ASSET MANAGEMENT INC | $1.890.660 | 132.214 | 0,16% | Ações |
| Corient Private Wealth LP | $1.827.526 | 127.799 | 0,16% | Ações |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1.740.081 | 121.684 | 0,15% | Ações |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.548.690 | 108.300 | 0,13% | Opção de compra |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.548.690 | 108.300 | 0,13% | Opção de venda |
| DIADEMA PARTNERS LP | $1.520.090 | 106.300 | 0,13% | Opção de compra |
| SILVERBACK ASSET MANAGEMENT LLC | $1.430.000 | 100.000 | 0,12% | Opção de compra |
| Squarepoint Ops LLC | $1.401.429 | 98.002 | 0,12% | Ações |
| RHUMBLINE ADVISERS | $1.393.341 | 97.437 | 0,12% | Ações |
| CITADEL ADVISORS LLC | $1.357.070 | 94.900 | 0,12% | Opção de compra |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.354.752 | 105.101 | 0,12% | Ações |
| ALGERT GLOBAL LLC | $1.129.557 | 78.990 | 0,10% | Ações |
| Waverly Advisors, LLC | $1.114.170 | 77.914 | 0,10% | Ações |
| Cinctive Capital Management LP | $1.037.923 | 72.582 | 0,09% | Ações |
| Caption Management, LLC | $1.036.750 | 72.500 | 0,09% | Opção de compra |
| WELLINGTON MANAGEMENT GROUP LLP | $1.035.134 | 72.387 | 0,09% | Ações |
| GOLDMAN SACHS GROUP INC | $1.002.430 | 70.100 | 0,09% | Opção de compra |
| DEUTSCHE BANK AG\ | $989.860 | 69.221 | 0,09% | Ações |
| Bank of New York Mellon Corp | $981.824 | 68.659 | 0,08% | Ações |
| WOODSTOCK CORP | $979.049 | 68.465 | 0,08% | Ações |
| ALLIANCEBERNSTEIN L.P. | $971.081 | 75.336 | 0,08% | Ações |
| BANK OF AMERICA CORP /DE/ | $930.186 | 65.048 | 0,08% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $865.708 | 60.539 | 0,07% | Ações |
| FOX RUN MANAGEMENT, L.L.C. | $836.950 | 58.528 | 0,07% | Ações |
| Y-Intercept (Hong Kong) Ltd | $732.017 | 51.190 | 0,06% | Ações |
| SILVERBACK ASSET MANAGEMENT LLC | $715.000 | 50.000 | 0,06% | Ações |
| JANE STREET GROUP, LLC | $715.000 | 50.000 | 0,06% | Opção de compra |
| Erste Asset Management GmbH | $705.500 | 50.000 | 0,06% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $702.545 | 49.129 | 0,06% | Ações |
| Point72 Asset Management, L.P. | $694.608 | 48.574 | 0,06% | Ações |
| SBI Okasan Asset Management Co.Ltd. | $644.827 | 45.700 | 0,06% | Ações |
| MetLife Investment Management, LLC | $621.607 | 43.469 | 0,05% | Ações |
| JANE STREET GROUP, LLC | $597.954 | 41.815 | 0,05% | Ações |
| SCOTIA CAPITAL INC. | $597.039 | 41.751 | 0,05% | Ações |
Executivos da empresa 25 insiders · 12 diretores · 16 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Jay S. Duker | President and CEO | 10 de Julho de 2026 M | 9.594 | 0 | 0 | $0 |
| Nancy Lurker | President & CEO | 12 de Outubro de 2018 A | 211.700 | 0 | 0 | $0 |
| Paul Ashton | President & CEO | 18 de Março de 2016 M | 450.741 | 0 | 0 | $0 |
| David Price | Chief Financial Officer | 1 de Agosto de 2018 A | — | 0 | 0 | $0 |
| Michael Soja | VP Finance, CFO & Treasurer | 10 de Setembro de 2008 A | — | 0 | 0 | $0 |
| Ramiro Ribeiro | Chief Medical Officer | 30 de Junho de 2026 M | 0 | 0 | 2 | $-73.174 |
| Leonard S Ross | Vice President of Finance and Chief Accounting Officer | 22 de Dezembro de 2018 M | 76.187 | 0 | 0 | $0 |
| Dario A. Paggiarino | Chief Medical Officer | 12 de Outubro de 2018 F | 29.600 | 0 | 0 | $0 |
| Leonard M Blum | Executive VP and General Manager, US | 14 de Maio de 2018 A | — | 0 | 0 | $0 |
| Debora Jorn | EVP, Corp. & Comm'l Dev. | 27 de Junho de 2017 A | — | 0 | 0 | $0 |
| Lori Freedman | VP Corporate Affairs, General Counsel and Secretary | 21 de Julho de 2016 A | 96.423 | 0 | 0 | $0 |
| Aaron Finlay | Secretary | 18 de Outubro de 2007 A | — | 0 | 0 | $0 |
| Karen L. Zaderej | Conselheiro | 18 de Agosto de 2026 P | 49.100 | 1 | 0 | $52.258 |
| Wendy F Dicicco | Conselheiro | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| ANDO GORAN | Conselheiro | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Fred Hassan | Conselheiro | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Michael W Rogers | Conselheiro | 15 de Novembro de 2018 M | 112.500 | 0 | 0 | $0 |
| John B. Landis | Conselheiro | 25 de Outubro de 2018 A | — | 0 | 0 | $0 |
| David J Mazzo | Conselheiro | 6 de Setembro de 2018 A | 138.000 | 0 | 0 | $0 |
| Douglas Evan Godshall | Conselheiro | 27 de Junho de 2018 M | 12.500 | 0 | 0 | $0 |
| James J Barry | Conselheiro | 7 de Maio de 2018 M | 12.500 | 0 | 0 | $0 |
| Kristine Peterson | Conselheiro | 15 de Dezembro de 2017 A | — | 0 | 0 | $0 |
| SAVAS PETER G | Conselheiro | 3 de Dezembro de 2015 A | — | 0 | 0 | $0 |
| Paul Hopper | Conselheiro | 18 de Dezembro de 2013 A | 10.000 | 0 | 0 | $0 |
| Katherine Woodthorpe | Conselheiro | 27 de Novembro de 2007 A | — | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 5 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 declarações | 8 de Dezembro de 2023 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 30 de Agosto de 2023 | — | Declaração inicial | — | SEC |
| Ocumension Therapeutics | 22 de Janeiro de 2021 | — | Declaração inicial | — | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 declarações | 26 de Maio de 2017 | — | Declaração inicial | — | SEC |
| Pfizer Inc. | 17 de Julho de 2007 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 42 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,18% | 11.564 NS | 30 de Abril de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,61% | 17.260 NS | 30 de Abril de 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,51% | 8.244 SH | 8 de Agosto de 2026 | Diário |
| IWC · iShares Trust | 0,23% | 262.360 SH | 8 de Agosto de 2026 | Diário |
| IHE · iShares Trust | 0,22% | 281.199 SH | 8 de Agosto de 2026 | Diário |
| FSCC · Federated Hermes ETF Trust | 0,12% | 25.180 NS | 31 de Maio de 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,08% | 78.250 NS | 30 de Abril de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 4.561 SH | 8 de Agosto de 2026 | Diário |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 86.797 SH | 8 de Agosto de 2026 | Diário |
| BIB · ProShares Trust | 0,06% | 3.062 NS | 31 de Maio de 2026 | N-PORT |
| IWO · iShares Trust | 0,05% | 592.383 SH | 8 de Agosto de 2026 | Diário |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,05% | 69.310 SH | 8 de Agosto de 2026 | Diário |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 25.575 NS | 31 de Maio de 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.980.136 SH | 8 de Agosto de 2026 | Diário |
| RSSL · Global X Funds | 0,03% | 33.518 NS | 30 de Abril de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 445.218 SH | 8 de Agosto de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 61.360 SH | 8 de Agosto de 2026 | Diário |
| ISCV · iShares Trust | 0,03% | 15.627 SH | 8 de Agosto de 2026 | Diário |
| ITWO · ProShares Trust | 0,03% | 3.648 NS | 31 de Maio de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 378.469 NS | 31 de Maio de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 34.174 NS | 30 de Abril de 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2.853 NS | 31 de Maio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 152.391 NS | 30 de Abril de 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 3.155 SH | 8 de Agosto de 2026 | Diário |
| URTY · ProShares Trust | 0,01% | 2.885 NS | 31 de Maio de 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 120.933 SH | 8 de Agosto de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 901.417 SH | 8 de Agosto de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 11.210 SH | 8 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,01% | 213.549 SH | 8 de Agosto de 2026 | Diário |
| WSML · iShares Trust | 0,01% | 4.526 SH | 8 de Agosto de 2026 | Diário |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2.895 NS | 31 de Maio de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 72 NS | 31 de Maio de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 28.026 NS | 31 de Maio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3.564 NS | 30 de Abril de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 111.667 SH | 8 de Agosto de 2026 | Diário |
| IWV · iShares Trust | 0,00% | 21.976 SH | 8 de Agosto de 2026 | Diário |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 46.188 NS | 31 de Maio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.667 NS | 30 de Abril de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 41.879 NS | 30 de Abril de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 13.282 NS | 30 de Abril de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.643.860 SH | 8 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.035 SH | 8 de Agosto de 2026 | Diário |